Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.755 USD | +1.50% | +2.95% | -48.71% |
Mar. 12 | 908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies | CI |
Mar. 05 | Transcript : 908 Devices Inc., Q4 2023 Earnings Call, Mar 05, 2024 |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,492 | 803.3 | 241.6 | 363.3 | 186.6 | - |
Enterprise Value (EV) 1 | 1,355 | 803.3 | 241.6 | 363.3 | 186.6 | 186.6 |
P/E ratio | -24.2 x | -32.7 x | -7.12 x | -9.93 x | -4.53 x | -5.02 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 55.5 x | 19 x | 5.16 x | 7.23 x | 3.53 x | 2.99 x |
EV / Revenue | 55.5 x | 19 x | 5.16 x | 7.23 x | 3.53 x | 2.99 x |
EV / EBITDA | -299 x | -43.1 x | -9.1 x | - | -5.15 x | -5.75 x |
EV / FCF | - | - | -10.5 x | - | -6.91 x | -6.91 x |
FCF Yield | - | - | -9.51% | - | -14.5% | -14.5% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 26,201 | 31,050 | 31,711 | 32,379 | 32,910 | - |
Reference price 2 | 56.95 | 25.87 | 7.620 | 11.22 | 5.670 | 5.670 |
Announcement Date | 3/30/21 | 3/7/22 | 3/7/23 | 3/5/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 26.89 | 42.21 | 46.85 | 50.23 | 52.9 | 62.38 |
EBITDA 1 | - | -4.984 | -18.64 | -26.56 | - | -36.26 | -32.47 |
EBIT 1 | - | -5.815 | -22.07 | -35.38 | -42.76 | -43.36 | -40.14 |
Operating Margin | - | -21.62% | -52.29% | -75.52% | -85.13% | -81.95% | -64.34% |
Earnings before Tax (EBT) 1 | - | - | - | -33.56 | -36.61 | -42.59 | -39.74 |
Net income 1 | -13.48 | -12.91 | -22.17 | -33.56 | -36.4 | -41.59 | -38.54 |
Net margin | - | -48% | -52.53% | -71.64% | -72.47% | -78.61% | -61.78% |
EPS 2 | -1.660 | -2.350 | -0.7900 | -1.070 | -1.130 | -1.252 | -1.130 |
Free Cash Flow 1 | - | - | - | -22.98 | - | -27 | -27 |
FCF margin | - | - | - | -49.04% | - | -51.04% | -43.28% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 10/2/20 | 3/30/21 | 3/7/22 | 3/7/23 | 3/5/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 12.54 | 15.84 | 8.306 | 11.11 | 15.8 | 11.64 | 9.487 | 12.09 | 14.3 | 14.35 | 9.292 | 12.28 | 14.77 | 16.56 | 11.5 |
EBITDA 1 | -5.015 | -2.366 | -9.254 | -8.058 | -6.695 | -7.757 | -12.38 | -10.33 | -8.349 | - | -10.99 | -9.264 | -8.647 | -7.358 | -8.085 |
EBIT 1 | -5.276 | -3.528 | -9.521 | -8.369 | -7.154 | -10.34 | -13.02 | -10.94 | -9.089 | -9.713 | -12.65 | -11.06 | -10.45 | -9.191 | -12.54 |
Operating Margin | -42.06% | -22.27% | -114.63% | -75.36% | -45.29% | -88.79% | -137.21% | -90.45% | -63.57% | -67.68% | -136.17% | -90.1% | -70.73% | -55.5% | -109% |
Earnings before Tax (EBT) 1 | - | - | - | - | -6.259 | -9.791 | -12.53 | -9.417 | -7.18 | -7.431 | -12.47 | -10.85 | -10.26 | -8.975 | -12.04 |
Net income 1 | -5.185 | -3.465 | -9.415 | -8.099 | -6.259 | -9.791 | -12.53 | -9.346 | -7.093 | -7.429 | -12.1 | -10.61 | -9.978 | -8.872 | -12.04 |
Net margin | -41.33% | -21.87% | -113.35% | -72.92% | -39.62% | -84.09% | -132.1% | -77.28% | -49.61% | -51.77% | -130.27% | -86.4% | -67.56% | -53.57% | -104.65% |
EPS 2 | -0.1900 | -0.1200 | -0.3000 | -0.2600 | -0.2000 | -0.3100 | -0.3900 | -0.2900 | -0.2200 | -0.2300 | -0.3620 | -0.3200 | -0.3020 | -0.2700 | -0.3400 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/4/21 | 3/7/22 | 5/10/22 | 8/9/22 | 11/14/22 | 3/7/23 | 5/9/23 | 8/8/23 | 11/7/23 | 3/5/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | 137 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | -23 | - | -27 | -27 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 0.01 | - | 2.05 | - | 2 | 3 |
Capex / Sales | - | 0.03% | - | 4.36% | - | 3.78% | 4.81% |
Announcement Date | 10/2/20 | 3/30/21 | 3/7/22 | 3/7/23 | 3/5/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.71% | 187M | |
-12.42% | 19.08B | |
-46.59% | 2.65B | |
+17.50% | 1.87B | |
-0.58% | 1.61B | |
+25.36% | 1.21B | |
-8.67% | 1.02B | |
-21.91% | 905M | |
-4.42% | 716M | |
-17.51% | 682M |
- Stock Market
- Equities
- MASS Stock
- Financials 908 Devices Inc.